Fair call. I'm frustrated too, but there has been a lot of ahhing and umming about the results which I see as utterly unjustified. I'm very confident about them overall and so am not really worried about this one, though it will be great if it comes out positive like everything else has. The marketing is coming, and on the back of patients doing better than expected, and this will burst the cone of silence around this company. That's my call at this stage. Am I wrong? We'll see.
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed, page-136
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.3¢ |
Change
-0.008(4.17%) |
Mkt cap ! $83.90M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.3¢ | $59.77K | 338.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 376984 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 25091 | 2 |
View Market Depth
| Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |